217 related articles for article (PubMed ID: 17584491)
1. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.
Newell ML; Huang S; Fiore S; Thorne C; Mandelbrot L; Sullivan JL; Maupin R; Delke I; Watts DH; Gelber RD; Cunningham CK;
BMC Infect Dis; 2007 Jun; 7():60. PubMed ID: 17584491
[TBL] [Abstract][Full Text] [Related]
2. Mode of delivery in HIV-infected pregnant women and prevention of mother-to-child transmission: changing practices in Western Europe.
; Boer K; England K; Godfried MH; Thorne C
HIV Med; 2010 Jul; 11(6):368-78. PubMed ID: 20059573
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
4. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
[TBL] [Abstract][Full Text] [Related]
5. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.
European Collaborative Study
Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcomes of women with HIV in a district general hospital in the UK.
Carey L; Desouza C; Moorcroft A; Elgalib A
J Obstet Gynaecol; 2018 Aug; 38(6):777-780. PubMed ID: 29526132
[TBL] [Abstract][Full Text] [Related]
7. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10.
Thorne C; Semenenko I; Malyuta R;
Addiction; 2012 Jan; 107(1):118-28. PubMed ID: 21819473
[TBL] [Abstract][Full Text] [Related]
8. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
9. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
[TBL] [Abstract][Full Text] [Related]
10. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
[TBL] [Abstract][Full Text] [Related]
11. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.
Chiappini E; Galli L; Giaquinto C; Ene L; Goetghebuer T; Judd A; Lisi C; Malyuta R; Noguera-Julian A; Ramos JT; Rojo-Conejo P; Rudin C; Tookey P; de Martino M; Thorne C;
AIDS; 2013 Mar; 27(6):991-1000. PubMed ID: 23211776
[TBL] [Abstract][Full Text] [Related]
12. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
[TBL] [Abstract][Full Text] [Related]
13. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
14. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West.
European Collaborative Study
AIDS; 2006 Jun; 20(10):1419-27. PubMed ID: 16791017
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1.
Read JS; Newell MK
Cochrane Database Syst Rev; 2005 Oct; (4):CD005479. PubMed ID: 16235405
[TBL] [Abstract][Full Text] [Related]
16. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
17. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.
Aebi-Popp K; Mulcahy F; Glass TR; Rudin C; Martinez de Tejada B; Bertisch B; Fehr J; Grawe C; Scheibner K; Rickenbach M; Hoesli I; Thorne C; ;
J Acquir Immune Defic Syndr; 2013 Sep; 64(1):58-65. PubMed ID: 23842074
[TBL] [Abstract][Full Text] [Related]
18. Injecting drug use in pregnant HIV-infected women in Europe.
Thorne C; Newell ML
Med Wieku Rozwoj; 2006; 10(4):1005-16. PubMed ID: 17426368
[TBL] [Abstract][Full Text] [Related]
19. Mother-to-child transmission of HIV: experience at a referral hospital in Saudi Arabia.
Edathodu J; Halim MM; Dahham MB; Alrajhi AA
Ann Saudi Med; 2010; 30(1):15-7. PubMed ID: 20103953
[TBL] [Abstract][Full Text] [Related]
20. Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.
Thorne C; Semenenko I; Pilipenko T; Malyuta R;
BMC Infect Dis; 2009 Apr; 9():40. PubMed ID: 19351387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
